Frontlight ResearchEarly access
Trial site
Orange Health Service
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Prostate cancer3 trials
- Liver and biliary tract cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Mesothelioma1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- Thyroid cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Amgen1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Fore Biotherapeutics1 trial
- Olivia Newton-John Cancer Research Institute1 trial
- Pfizer1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Combination Immunotherapy in Rare Cancers Under InvesTigation
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026